Product Description
For mild to moderate acne vulgaris (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01494285)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: Topical
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: M. Arkin 1999
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Acne Vulgaris
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
MA1001 | P2 |
Completed |
Acne Vulgaris |
2013-10-01 |